NCT04536961View on ClinicalTrials.gov

A Study to Evaluate the Drug Levels of BMS-986165 When Taken as Various Solid Tablet Prototypes by Healthy Participants

PHASE1CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

September 10, 2020

Primary Completion Date

December 25, 2020

Study Completion Date

December 25, 2020

Conditions
Healthy Volunteers
Interventions
DRUG

Reference Treatment- BMS-986165-01

Specified dose on specified days

DRUG

Prototype BMS-986165

Specified dose on specified days

DRUG

Famotidine

Specified dose on specified days

OTHER

Alcohol

Specified quantity on specified days

Trial Locations (1)

NG11 6JS

Quotient Sciences Miami, Nottingham

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY